These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22542920)

  • 1. TPMT status determination: the simplest is the most effective?
    Chouchana L; Narjoz C; Loriot MA
    J Crohns Colitis; 2012 Aug; 6(7):807; author reply 808. PubMed ID: 22542920
    [No Abstract]   [Full Text] [Related]  

  • 2. Genotyping should be considered the primary choice for pre-treatment evaluation of thiopurine methyltransferase function.
    Hindorf U; Appell ML
    J Crohns Colitis; 2012 Jul; 6(6):655-9. PubMed ID: 22398041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiopurine dose in intermediate and normal metabolizers of thiopurine methyltransferase may differ three-fold.
    Gardiner SJ; Gearry RB; Begg EJ; Zhang M; Barclay ML
    Clin Gastroenterol Hepatol; 2008 Jun; 6(6):654-60; quiz 604. PubMed ID: 18467186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic polymorphism and treatment of chronic bowel inflammatory diseases: the example of azathioprine].
    Bessard G; Hardy G; Chartier A; Stanke-Labesque F
    Therapie; 2004; 59(1):71-5. PubMed ID: 15199672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing the therapeutic potential of azathioprine/6-mercaptopurine in the treatment of inflammatory bowel disease.
    Papadakis KA
    J Clin Gastroenterol; 2003; 36(5):379-81. PubMed ID: 12702974
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioequivalence of azathioprine products.
    Baker DE
    Rev Gastroenterol Disord; 2003; 3(4):219-23. PubMed ID: 14668694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing thiopurine therapy in inflammatory bowel disease.
    Chevaux JB; Peyrin-Biroulet L; Sparrow MP
    Inflamm Bowel Dis; 2011 Jun; 17(6):1428-35. PubMed ID: 20949566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azathioprine intolerance in patients with IBD may be imidazole-related and is independent of TPMT activity.
    McGovern DP; Travis SP; Duley J; Shobowale-Bakre el M; Dalton HR
    Gastroenterology; 2002 Mar; 122(3):838-9. PubMed ID: 11878296
    [No Abstract]   [Full Text] [Related]  

  • 9. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
    Fangbin Z; Xiang G; Minhu C; Liang D; Feng X; Min H; Pinjin H
    Ther Drug Monit; 2012 Dec; 34(6):695-701. PubMed ID: 23149442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics and IBD: TPMT and thiopurines.
    Sandborn WJ
    Inflamm Bowel Dis; 2004 Feb; 10 Suppl 1():S35-7. PubMed ID: 15168829
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of thiopurine testing in the management of inflammatory bowel diseases in clinical practice: a worldwide survey of experts.
    Roblin X; Oussalah A; Chevaux JB; Sparrow M; Peyrin-Biroulet L
    Inflamm Bowel Dis; 2011 Dec; 17(12):2480-7. PubMed ID: 21351210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of thiopurine methyltransferase mutation in patients of Mediterranean area with inflammatory bowel disease and autoimmune disorders.
    Di Salvo A; Fabiano C; Mannara V; Dimarco M; Orlando A; Affronti M; Macaluso FS; Cottone M
    Dig Liver Dis; 2016 Dec; 48(12):1506-1509. PubMed ID: 27665263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis.
    Heneghan MA; Allan ML; Bornstein JD; Muir AJ; Tendler DA
    J Hepatol; 2006 Oct; 45(4):584-91. PubMed ID: 16876902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological and pharmacogenetic study of two immunomodulators: azathioprine and 6-mercaptopurine. Strategies for preventing complications].
    Wolf A; Burnat P; Garcia-Hejl C; Ceppa F
    Gastroenterol Clin Biol; 2009 Mar; 33(3):176-84. PubMed ID: 19243907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steady-state of azathioprine during initiation treatment of pediatric inflammatory bowel disease.
    Pozler O; Chládek J; Malý J; Hroch M; Dědek P; Beránek M; Krásničanová P
    J Crohns Colitis; 2010 Dec; 4(6):623-8. PubMed ID: 21122571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacogenetic study of thiopurine S-methyltransferase (TPMT) and thiopurine toxicity].
    Corominas H; Díaz C; Vázquez G; Baiget M
    Rev Esp Enferm Dig; 2002 Oct; 94(10):635-6. PubMed ID: 12647415
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial: thiopurine-induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype-the perils of ageing.
    Willington AJ; Gearry RB
    Aliment Pharmacol Ther; 2018 Jan; 47(1):129-130. PubMed ID: 29226409
    [No Abstract]   [Full Text] [Related]  

  • 18. Thiopurine methyltransferase activity in the Jewish population of Israel.
    Lowenthal A; Meyerstein N; Ben-Zvi Z
    Eur J Clin Pharmacol; 2001 Apr; 57(1):43-6. PubMed ID: 11372589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial: thiopurine-induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype-the perils of ageing. Authors' reply.
    Broekman MMTJ; Wanten GJ; de Jong DJ
    Aliment Pharmacol Ther; 2018 Jan; 47(1):130-131. PubMed ID: 29226420
    [No Abstract]   [Full Text] [Related]  

  • 20. TPMT genotype and the use of thiopurines in paediatric inflammatory bowel disease.
    Stocco G; Martelossi S; Barabino A; Fontana M; Lionetti P; Decorti G; Malusà N; Bartoli F; Fezzi M; Giraldi T; Ventura A
    Dig Liver Dis; 2005 Dec; 37(12):940-5. PubMed ID: 16202677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.